CDK4/6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: Are we at the finish line?

Clinton Yam, Mien-Chie Hung, Gabriel N. Hortobagyi
2018 OncoTarget  
doi:10.18632/oncotarget.26134 fatcat:3wmdrxmdpbfobc35ekiwmpyuau